Table 2.
Number of Patients With Bleeding or New Cancer Diagnosis and the Percentage of New Cancers Diagnosed in Patients With Bleeding According to Bleeding Site
| Patients With Bleeding, n | Patients With Cancer, n (%) | |||||
|---|---|---|---|---|---|---|
| Organ System | Any Bleeding | Major Bleeding | CIF Cancer (Per 100 Patient‐y) | Total Patients | In Patients With Bleeding | In Patients With Major Bleeding |
| Any | 2171 | 623 | 4.7 (4.1–5.4) | 479 | 198* (41.3) | 78* (16.3) |
| Gastrointestinal* | 458 | 197 | 6.2 (4.5–8.7) | 162 | 42* (25.9) | 28* (17.3) |
| Genitourinary* | 429 | 79 | 6.0 (4.5–8.0) | 139 | 44* (31.7) | 18* (12.9) |
| Bronchopulmonary* | 111 | 21 | 2.1 (0.9–4.9) | 37 | 5* (13.5) | 1* (2.7) |
| Other sites* | 1173 | 326 | 1.1 (0.8–1.7) | 141 | 26* (18.4) | 3* (2.1) |
CIF indicates cumulative incidence function.
a
The number of specific cancers is reported based on the location of the bleeding.